Puig-Tintoré Luis M, Ordi Jaume, Vidal-Sicart Sergi, Lejárcegui José A, Torné Aureli, Pahisa Jaume, Iglesias Xavier
Section of Gynecologic Oncology, Institut Clínic de Ginecologia, Obstetrícia i Neonatología (ICGON), Hospital Clínic, Institut d'investigacions biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Spain.
Gynecol Oncol. 2003 Jan;88(1):29-34. doi: 10.1006/gyno.2002.6857.
The aim was to determine the feasibility of surgical identification and pathological ultrastaging of sentinel nodes (SNs) in vulvar carcinoma and to evaluate whether SN negativity rules out the possibility of metastasis in other nodes and can therefore avoid conventional lymphadenectomy.
In 26 patients with vulvar squamous cell carcinoma the SNs were detected using both peritumoral injection of (99m)Tc and blue dye (isosulfan or methylene) before the surgical procedure. Dissection of the SNs was followed by standard lymphadenectomy and vulvar exeresis. For pathological ultrastaging at least eight histological sections of every node separated 400 microm were evaluated using hematoxylin & eosin and immunostaining against cytokeratin.
We identified the SNs in 25/26 patients (96%). In 19 patients (76%) the SN was unilateral and in 6 (24%) it was bilateral. A total of 46 SNs were isolated. Metastatic carcinoma was identified in 9 SNs from 8 patients (30.8%). Thirty-eight percent (3 of 8) patients with metastatic SNs presented micrometastasis detected only in ultrastaging. Seven (3.3%) of 239 nonsentinel nodes (non-SNs) showed metastasis. No metastatic implant was detected in non-SNs when SNs were negative in patients without clinical suspicious adenopathy (100% negative predictive value).
Inguinofemoral lymph nodes can be confidently avoided when sentinel node metastases are excluded by histological ultrastaging. This may reduce the surgical morbidity of conventional inguinofemoral lymphadenectomy, without worsening vulvar cancer prognosis.
本研究旨在确定前哨淋巴结(SN)手术识别及病理超分期在外阴癌中的可行性,并评估SN阴性是否可排除其他淋巴结转移的可能性,从而避免传统淋巴结清扫术。
26例外阴鳞状细胞癌患者在手术前通过肿瘤周围注射(99m)Tc和蓝色染料(异硫蓝或亚甲蓝)检测SN。切除SN后进行标准淋巴结清扫术及外阴切除术。对于病理超分期,每个淋巴结至少取8个间隔400微米的组织切片,用苏木精和伊红染色以及细胞角蛋白免疫染色进行评估。
25/26例患者(96%)成功识别出SN。19例患者(76%)的SN为单侧,6例(24%)为双侧。共分离出46个SN。8例患者的9个SN中发现转移癌(30.8%)。8例有转移SN的患者中,38%(3/8)仅在超分期时检测到微转移。239个非前哨淋巴结(non-SN)中有7个(3.3%)出现转移。在无临床可疑淋巴结病且SN为阴性的患者中,non-SN未检测到转移灶(阴性预测值100%)。
当组织学超分期排除前哨淋巴结转移时,可放心避免腹股沟股淋巴结清扫。这可能降低传统腹股沟股淋巴结清扫术的手术并发症,且不会恶化外阴癌预后。